n Obstetrics and Gynaecology Forum - Longest-ever study of post-menopausal osteoporosis therapy : product news

Volume 15, Issue 4
  • ISSN : 1027-9148



Extracted from text ... Obstetrics & Gynaecology Forum ? October 2005 27 Longest-Ever Study of Post-Menopausal Osteoporosis Therapy In the longest, randomised clinical trial ever conducted of treatment for osteoporosis, researchers found that post-menopausal women taking FOSAMAX(r) (alendronate sodium) experienced significant (p < 0.001) increases in bone mineral density (BMD) at the hip and spine at 10 years of treatment. FOSAMAX is the most-prescribed medicine worldwide for the treatment of postmenopausal, male and glucocorticoid-induced osteoporosis with more than 20 million patient years of therapy prescribed. FOSAMAX is the only osteoporosis therapy with proven efficacy through ten years. "Assessing the effect of treatment over time ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error